Pliant Therapeutics files initial beneficial ownership statement for Chief Medical Officer David Raben

• Pliant Therapeutics filed a Form 3 for David Raben, its chief medical officer, dated Sept. 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pliant Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001746473-26-000116), on October 02, 2026, and is solely responsible for the information contained therein.